Publicacións en colaboración con investigadores/as de Centro de Investigación en Red en Enfermedades Cardiovasculares (32)

2022

  1. Sex Differences in Low-Density Lipoprotein Cholesterol Reduction with PCSK9 Inhibitors in Real-world Patients: The LIPID-REAL Registry

    Journal of Cardiovascular Pharmacology, Vol. 79, Núm. 4, pp. 523-529

2021

  1. Acute coronary syndrome in the older patient

    Journal of Clinical Medicine, Vol. 10, Núm. 18

  2. Comorbidity burden and revascularization benefit in elderly patients with acute coronary syndrome

    Revista Espanola de Cardiologia, Vol. 74, Núm. 9, pp. 765-772

  3. Direct Oral Anticoagulants Versus Vitamin-K Antagonist After PCIs in Patients With AF: A Meta-analysis of Cardiac Ischemic Events

    Journal of cardiovascular pharmacology, Vol. 77, Núm. 2, pp. 164-169

  4. Impact of comorbidities in the decision of using invasive management in elderly patients with NSTEACS

    REC: Interventional Cardiology, Vol. 3, Núm. 1, pp. 15-20

  5. Lipid lowering treatment in patients with very high risk cardiovascular disease. Spanish Society of Cardiology Consensus Document for the use of PCSK9 inhibitors in clinical practice

    REC: CardioClinics, Vol. 56, Núm. 1, pp. 39-48

  6. Managing NSTEMI in older patients

    The Lancet

  7. Mortality associated with cardiovascular disease in patients with COVID-19

    REC: CardioClinics, Vol. 56, Núm. 1, pp. 30-38

  8. New-onset heart failure after acute coronary syndrome in patients without heart failure or left ventricular dysfunction

    Revista Espanola de Cardiologia, Vol. 74, Núm. 6, pp. 494-501

  9. Removal of the intermediate risk group in the latest European guidelines for NSTEACS: is it justified?

    Revista Espanola de Cardiologia, Vol. 74, Núm. 10, pp. 891-893

  10. Selection of the best of 2020 in geriatric cardiology

    REC: CardioClinics, Vol. 56, pp. 3-8

  11. Soluble ST2 and Diuretic Efficiency in Acute Heart Failure and Concomitant Renal Dysfunction

    Journal of Cardiac Failure, Vol. 27, Núm. 4, pp. 427-434

2020

  1. CA125-Guided Diuretic Treatment Versus Usual Care in Patients With Acute Heart Failure and Renal Dysfunction

    American Journal of Medicine, Vol. 133, Núm. 3, pp. 370-380.e4

  2. Cardiovascular complications and prognosis in COVID-19 patients

    Revista Espanola de Cardiologia Suplementos, Vol. 20, Núm. SE, pp. 9-13

  3. Early revascularization and long-term mortality in high-risk patients with non–ST-elevation myocardial infarction. The CARDIOCHUS-HUSJ registry

    Revista Espanola de Cardiologia, Vol. 73, Núm. 1, pp. 35-42

  4. Effect of insulin on readmission for heart failure following a hospitalization for acute heart failure

    ESC Heart Failure, Vol. 7, Núm. 6, pp. 3320-3328

  5. Estimation of the major cardiovascular events prevention with Inclisiran

    Atherosclerosis, Vol. 313, pp. 76-80

  6. Long-term bleeding risk vs. mortality risk in acute coronary syndrome patients according to the 2019 ARC-HBR definition

    Thrombosis Research

  7. Prevention of myocardial infarction and stroke with PCSK9 inhibitors treatment: a metanalysis of recent randomized clinical trials

    Journal of Diabetes and Metabolic Disorders, Vol. 19, Núm. 2, pp. 759-765

  8. Sex-related differences in long-term mortality and heart failure in a contemporary cohort of patients with NSTEACS. The cardiochus-HSUJ registry

    European Journal of Internal Medicine, Vol. 81, pp. 26-31